AUTHOR INDEX
 |
|
| Browse by letter: |
|
|
|
|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
|
|
|
|
|
|
|
|
|
|
Search results for: "V"
Results 171 - 180 of 260 shown below |
|
|
|
|
|
|
|
| Voigt, Karlheinz |
|
| Thomas Penzel, Jan W Kantelhardt, Chung-Chang Lo, Karlheinz Voigt and Claus Vogelmeier Dynamics of Heart Rate and Sleep Stages in Normals and Patients with Sleep Apnea doi:10.1038/sj.npp.1300146 Neuropsychopharmacology 28, S48-S53 | Abstract | Full text | PDF | |
|
|
|
| Voikar, Vootele |
|
| Janne Tornberg, Mikael Segerstråle, Natalia Kulesskaya, Vootele Voikar, Tomi Taira and Matti S Airaksinen KCC2-Deficient Mice Show Reduced Sensitivity to Diazepam, but Normal Alcohol-Induced Motor Impairment, Gaboxadol-Induced Sedation, and Neurosteroid-Induced Hypnosis doi:10.1038/sj.npp.1301195 Neuropsychopharmacology 32, 911-918 | Abstract | Full text | PDF | |
|
|
|
| Vojvoda, Dolores |
|
| Ann M Rasmusson, Jitka Vasek, Deborah S Lipschitz, Dolores Vojvoda, Mary Ellen Mustone, Quihu Shi, Gretchen Gudmundsen, Charles A Morgan, Jessica Wolfe and Dennis S Charney An Increased Capacity for Adrenal DHEA Release is Associated with Decreased Avoidance and Negative Mood Symptoms in Women with PTSD doi:10.1038/sj.npp.1300432 Neuropsychopharmacology 29, 1546-1557 | Abstract | Full text | PDF | |
|
|
|
| Volavka, Jan |
|
| Robert M Bilder, Jan Volavka, Herbert M Lachman and Anthony A Grace The Catechol-O-Methyltransferase Polymorphism: Relations to the Tonic–Phasic Dopamine Hypothesis and Neuropsychiatric Phenotypes doi:10.1038/sj.npp.1300542 Neuropsychopharmacology 29, 1943-1961 | Abstract | Full text | PDF | |
|
|
|
| Jeffrey A Lieberman, Kelly Papadakis, John Csernansky, Robert Litman, Jan Volavka, Xinwei Daniel Jia and Allyson Gage A Randomized, Placebo-Controlled Study of Memantine as Adjunctive Treatment in Patients with Schizophrenia doi:10.1038/npp.2008.200 Neuropsychopharmacology 34, 1322-1329 | Abstract | Full text | PDF | |
|
|
|
| Volkerts, Edmund R |
|
| Joris C Verster, Danielle van Duin, Edmund R Volkerts, Antonia HCML Schreuder and Marinus N Verbaten Alcohol Hangover Effects on Memory Functioning and Vigilance Performance after an Evening of Binge Drinking doi:10.1038/sj.npp.1300090 Neuropsychopharmacology 28, 740-746 | Abstract | Full text | PDF | |
|
|
|
| Joris C Verster, Edmund R Volkerts and Marinus N Verbaten Effects of Alprazolam on Driving Ability, Memory Functioning and Psychomotor Performance: A Randomized, Placebo-controlled Study doi:10.1016/S0893-133X(02)00310-X Neuropsychopharmacology 27, 260-269 | Abstract | Full text | PDF | |
|
|
|
| Volkow, N D |
|
| N D Volkow, G -J Wang, J S Fowler, J Logan, R Hitzemann, S J Gatley, R R MacGregor and A P Wolf Cocaine Uptake Is Decreased in the Brain of Detoxified Cocaine Abusers doi:10.1016/0893-133X(95)00073-M Neuropsychopharmacology 14, 159-168 | Abstract | PDF | |
|
|
|
| Volkow, Nora D |
|
| Janusz Borycz, Agustin Zapata, César Quiroz, Nora D Volkow and Sergi Ferré 5-HT1B Receptor-Mediated Serotoninergic Modulation of Methylphenidate-Induced Locomotor Activation in Rats doi:10.1038/sj.npp.1301445 Neuropsychopharmacology 33, 619-626 | Abstract | Full text | PDF | |
|
|
|
| Nora D Volkow, Gene-Jack Wang, Robert Hitzemann, Joanna S Fowler, Naome Pappas, Patricia Lowrimore, Gail Burr, Katherine Pascani, John Overall and Alfred P Wolf Depression of Thalamic Metabolism by Lorazepam Is Associated with Sleepiness doi:10.1016/0893-133X(94)00068-B Neuropsychopharmacology 12, 123-132 | Abstract | PDF | |
|
|
|
| Gene-Jack Wang, Nora D Volkow, Joanna S Fowler, Jean Logan, Naji N Abumrad, Robert J Hitzemann, Naomi S Pappas and Kathy Pascani Dopamine D2 Receptor Availability in Opiate-Dependent Subjects before and after Naloxone-Precipitated Withdrawal doi:10.1016/S0893-133X(96)00184-4 Neuropsychopharmacology 16, 174-182 | Abstract | PDF | |
|
|
|
| Gwenn S Smith, Ralf Schloesser, Jonathan D Brodie, Stephen L Dewey, Jean Logan, Stephen A Vitkun, Philip Simkowitz, Arlene Hurley, Thomas Cooper, Nora D Volkow and Robert Cancro Glutamate Modulation of Dopamine Measured in Vivo with Positron Emission Tomography (PET) and 11C-Raclopride in Normal Human Subjects doi:10.1016/S0893-133X(97)00092-4 Neuropsychopharmacology 18, 18-25 | Abstract | PDF | |
|
|
|
| Onarae V Rice, S John Gatley, Ji Shen, Craig L Huemmer, Renata Rogoz, Onofre T DeJesus, Nora D Volkow and Andrew N Gifford Effects of Endogenous Neurotransmitters on the in vivo Binding of Dopamine and 5-HT Radiotracers in Mice doi:10.1016/S0893-133X(01)00287-1 Neuropsychopharmacology 25, 679-689 | Abstract | Full text | PDF | |
|
|
|
| Douglas A Marsteller, Madina R Gerasimov, Wynne K Schiffer, Justin M Geiger, Channing R Barnett, Jana Schaich Borg, Sabria Scott, Jill Ceccarelli, Nora D Volkow, Patricia E Molina, David L Alexoff and Stephen L Dewey Acute Handling Stress Modulates Methylphenidate-induced Catecholamine Overflow in the Medial Prefrontal Cortex doi:10.1016/S0893-133X(02)00288-9 Neuropsychopharmacology 27, 163-170 | Abstract | Full text | PDF | |
|
|
|
| Patricia A Woicik, Scott J Moeller, Nelly Alia-Klein, Thomas Maloney, Tanya M Lukasik, Olga Yeliosof, Gene-Jack Wang, Nora D Volkow and Rita Z Goldstein The Neuropsychology of Cocaine Addiction: Recent Cocaine Use Masks Impairment doi:10.1038/npp.2008.105 Neuropsychopharmacology 34, 1360-1360 | Abstract | Full text | PDF | |
|
|
|
| Patricia A Woicik, Scott J Moeller, Nelly Alia-Klein, Thomas Maloney, Tanya M Lukasik, Olga Yeliosof, Gene-Jack Wang, Nora D Volkow and Rita Z Goldstein The Neuropsychology of Cocaine Addiction: Recent Cocaine Use Masks Impairment doi:10.1038/npp.2008.60 Neuropsychopharmacology 34, 1112-1122 | Abstract | Full text | PDF | |
|
|
|
| George F Koob and Nora D Volkow Neurocircuitry of Addiction doi:10.1038/npp.2009.110 Neuropsychopharmacology 35, 217-238 | Abstract | Full text | PDF | |
|
|
|
| Vollenweider, F X |
|
| F X Vollenweider, K L Leenders, C Scharfetter, P Maguire, O Stadelmann and J Angst Positron Emission Tomography and Fluorodeoxyglucose Studies of Metabolic Hyperfrontality and Psychopathology in the Psilocybin Model of Psychosis doi:10.1016/S0893-133X(96)00246-1 Neuropsychopharmacology 16, 357-372 | Abstract | PDF | |
|
|
|
| Vollenweider, Franz X |
|
| Daniel Umbricht, Franz X Vollenweider, Liselotte Schmid, Claudia Grübel, Anja Skrabo, Theo Huber and Rene Koller Effects of the 5-HT2A Agonist Psilocybin on Mismatch Negativity Generation and AX-Continuous Performance Task: Implications for the Neuropharmacology of Cognitive Deficits in Schizophrenia doi:10.1038/sj.npp.1300005 Neuropsychopharmacology 28, 170-181 | Abstract | Full text | PDF | |
|
|
|
| Olivia L Carter, John D Pettigrew, Felix Hasler, Guy M Wallis, Guang B Liu, Daniel Hell and Franz X Vollenweider Modulating the Rate and Rhythmicity of Perceptual Rivalry Alternations with the Mixed 5-HT2A and 5-HT1A Agonist Psilocybin doi:10.1038/sj.npp.1300621 Neuropsychopharmacology 30, 1154-1162 | Abstract | Full text | PDF | |
|
|
|
| Franz X Vollenweider, Philipp A Csomor, Bernhard Knappe, Mark A Geyer and Boris B Quednow The Effects of the Preferential 5-HT2A Agonist Psilocybin on Prepulse Inhibition of Startle in Healthy Human Volunteers Depend on Interstimulus Interval doi:10.1038/sj.npp.1301324 Neuropsychopharmacology 32, 1876-1887 | Abstract | Full text | PDF | |
|
|
|
| Philipp A Csomor, Renée R Stadler, Joram Feldon, Benjamin K Yee, Mark A Geyer and Franz X Vollenweider Haloperidol Differentially Modulates Prepulse Inhibition and P50 Suppression in Healthy Humans Stratified for Low and High Gating Levels doi:10.1038/sj.npp.1301421 Neuropsychopharmacology 33, 497-512 | Abstract | Full text | PDF | |
|
|
|
| Franz X Vollenweider, Alex Gamma, Matthias Liechti and Theo Huber Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA ("Ecstasy") in MDMA-Naïve Healthy Volunteers doi:10.1038/sj.npp.1395197 Neuropsychopharmacology 19, 241-251 | Abstract | Full text | PDF | |
|
|
|
| Franz X Vollenweider, Peter Vontobel, Daniel Hell and Klaus L Leenders 5-HT Modulation of Dopamine Release in Basal Ganglia in Psilocybin-Induced Psychosis in Man—A PET Study with [11C]raclopride doi:10.1016/S0893-133X(98)00108-0 Neuropsychopharmacology 20, 424-433 | Abstract | Full text | PDF | |
|
|
|
| Franz X Vollenweider, Alex Gamma, Matthias Liechti and Theo Huber Is A Single Dose of MDMA Harmless doi:10.1016/S0893-133X(99)00032-9 Neuropsychopharmacology 21, 598-600 | Abstract | Full text | PDF | |
|
|
|
| Matthias E Liechti, Christine Baumann, Alex Gamma and Franz X Vollenweider Acute Psychological Effects of 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") are Attenuated by the Serotonin Uptake Inhibitor Citalopram doi:10.1016/S0893-133X(99)00148-7 Neuropsychopharmacology 22, 513-521 | Abstract | Full text | PDF | |
|
|
|
| Matthias E Liechti, Matthias R Saur, Alex Gamma, Daniel Hell and Franz X Vollenweider Psychological and Physiological Effects of MDMA ("Ecstasy") after Pretreatment with the 5-HT2 Antagonist Ketanserin in Healthy Humans doi:10.1016/S0893-133X(00)00126-3 Neuropsychopharmacology 23, 396-404 | Abstract | Full text | PDF | |
|
|
|
| Alex Gamma, Alfred Buck, Thomas Berthold, Daniel Hell and Franz X Vollenweider 3,4-Methylenedioxymethamphetamine (MDMA) Modulates Cortical and Limbic Brain Activity as Measured by [H215O]-PET in Healthy Humans doi:10.1016/S0893-133X(00)00130-5 Neuropsychopharmacology 23, 388-395 | Abstract | Full text | PDF | |
|
|
|
| Franz X Vollenweider Caveat Emptor: Editors Beware doi:10.1016/S0893-133X(00)00170-6 Neuropsychopharmacology 24, 461-463 | Abstract | Full text | PDF | |
|
|
|
| Matthias E Liechti, Mark A Geyer, Daniel Hell and Franz X Vollenweider Effects of MDMA (Ecstasy) on Prepulse Inhibition and Habituation of Startle in Humans after Pretreatment with Citalopram, Haloperidol, or Ketanserin doi:10.1016/S0893-133X(00)00199-8 Neuropsychopharmacology 24, 240-252 | Abstract | Full text | PDF | |
|
|
|
| Volosin, Marta |
|
| Silvia ME Kademian, Anahi E Bignante, Patricia Lardone, Bruce S McEwen and Marta Volosin Biphasic Effects of Adrenal Steroids on Learned Helplessness Behavior Induced by Inescapable Shock doi:10.1038/sj.npp.1300577 Neuropsychopharmacology 30, 58-66 | Abstract | Full text | PDF | |
|
|
|
|
|
|
|
|
|
| Result page | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | |
 Previous
|
Next 
|
|
|
|
|
|
|
top  |
|
|
|
